Antimicrobial Drug Discovery

Name: Antimicrobial Drug Discovery : Emerging Strategies
Price: 2644.0 NOK
Availability: InStock

Emerging Strategies

George Tegos (Redaktør) Eleftherios Mylonakis (Redaktør) Arnold Demain (Innledning) Hattie Gresham (Innledning) Eliora Ron (Innledning) Leonor Amaral (Innledning) Richard Cannon (Innledning) Karlett Parra (Innledning) Richard Calderon (Innledning) Kim Lewis (Innledning) Dulal Panda (Innledning) John F Kokai-Kun (Innledning) Paul Cotter (Innledning) Artem Cherkasov (Innledning) Andriy Luzhetskyy (Innledning) Grover L Waldrop (Innledning) Laura Cipolla (Innledning) Sanjay M Jachak (Innledning) Panagiotis Kastritsis (Innledning) Kim Hammond-Kosack (Innledning) Elaine Bignell (Innledning) Jeff Coleman (Innledning) Yiorgos Apidianakis (Innledning) Astrid van der Sar (Innledning) Lai Ren (Innledning) Jake Strouse (Innledning) Michael R Hamblin (Innledning) Sean P Nair (Innledning) Eric Bornstein (Innledning) Josh Nosanchuk (Innledning)

Gi vurdering

2644,-

Innbundet

Sendes innen 21 dager

Om boka Detaljer Oppdag mer

Drug resistance is increasing among a variety of human pathogenic microorganisms such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumaniii, Pseudomonas aeruginosa and Enterobacter spp. (currently dubbed the 'ESKAPE' pathogens), and has emerged as one of the most important clinical challenges of this century. Increased general awareness and fear of these pathogens means there is a growing demand for research to tackle the threat of multidrug resistance. Documenting the latest research in the field, this book discusses current and promising activities to discover new antimicrobials in five key areas: molecular genetics and systems microbiology; synthetic, computational chemistry and chemoinformatics; High Throughput Screening (HTS); non-vertebrate model hosts; and light- and nano-based technologies.